Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wellgistics Health (WGRX) EBITDA (2024 - 2025)

Wellgistics Health's EBITDA history spans 2 years, with the latest figure at $47.1 million for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 1357.74% year-over-year to $47.1 million, compared with a TTM value of -$21.3 million through Dec 2025, down 246.01%, and an annual FY2025 reading of -$21.3 million, down 246.01% over the prior year.
  • EBITDA for Q4 2025 was $47.1 million at Wellgistics Health, up from -$31.5 million in the prior quarter.
  • The five-year high for EBITDA was $47.1 million in Q4 2025, with the low at -$31.5 million in Q3 2025.